Patents by Inventor Hugh A. Edwards

Hugh A. Edwards has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10749773
    Abstract: Embodiments provide optimized deployment of workloads. A first workload to be deployed in at least one data center of a plurality of data centers is received. A first plurality of candidate data centers is selected from the plurality of data centers, and the first workload is deployed to each of the first plurality of candidate data centers. A first performance metric is collected from each respective data center of the first plurality of candidate data centers based on execution of the first workload deployed at the respective data centers, and a first optimal data center from the first plurality of candidate data centers is identified based on the first performance metrics. The first workload is removed from each of the first plurality of candidate data centers, other than the identified first optimal data center.
    Type: Grant
    Filed: July 6, 2018
    Date of Patent: August 18, 2020
    Assignee: International Business Machines Corporation
    Inventors: Hugh Edward Hockett, Lin Sun, Aaron James Quirk
  • Publication number: 20200214758
    Abstract: A vapor delivery device includes an induction coil system. The induction coil system can include a coiled fluid tube, a coiled wire, a capsule between the coiled fluid tube and the wire, and a cooling fluid supply configured to force a cooling fluid through the capsule across the coiled wire. The induction coil system can include a closed loop ferrite core, a wire coiled around a first portion of the ferrite core, and a fluid tube coiled around a second portion of the ferrite core. A wire coil can be contained in a cartridge system removably coupleable to a disposable vapor delivery device. The system can include a fluid flow controller and induction power regulation to maintain a specific operating pressure range for vapor within a uterus or other bodily cavity, tract, or duct.
    Type: Application
    Filed: December 19, 2019
    Publication date: July 9, 2020
    Applicant: AEGEA Medical Inc.
    Inventors: Daniel Van Zandt MOYER, Uriel Hiram CHEE, Torrey Pine SMITH, Hugh Edward MAGEN, Darin Charles GITTINGS
  • Publication number: 20200197068
    Abstract: A vapor delivery device includes an induction coil system. The induction coil system can include a coiled fluid tube, a coiled wire, a capsule between the coiled fluid tube and the wire, and a cooling fluid supply configured to force a cooling fluid through the capsule across the coiled wire. The induction coil system can include a closed loop ferrite core, a wire coiled around a first portion of the ferrite core, and a fluid tube coiled around a second portion of the ferrite core. A wire coil can be contained in a cartridge system removably coupleable to a disposable vapor delivery device. The system can include a fluid flow controller and induction power regulation to maintain a specific operating pressure range for vapor within a uterus or other bodily cavity, tract, or duct.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 25, 2020
    Applicant: AEGEA Medical Inc.
    Inventors: Daniel Van Zandt MOYER, Uriel Hiram CHEE, Torrey Pine SMITH, Hugh Edward MAGEN, Darin Charles GITTINGS
  • Publication number: 20200197081
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 25, 2020
    Inventors: Uriel Hiram CHEE, Robert Bilgor PELIKS, Hugh Edward MAGEN, Donnell William GURSKIS, Steven Robert BACICH
  • Publication number: 20200128632
    Abstract: A vapor delivery device includes an induction coil system. The induction coil system can include a coiled fluid tube, a coiled wire, a capsule between the coiled fluid tube and the wire, and a cooling fluid supply configured to force a cooling fluid through the capsule across the coiled wire. The induction coil system can include a closed loop ferrite core, a wire coiled around a first portion of the ferrite core, and a fluid tube coiled around a second portion of the ferrite core. A wire coil can be contained in a cartridge system removably coupleable to a disposable vapor delivery device. The system can include a fluid flow controller and induction power regulation to maintain a specific operating pressure range for vapor within a uterus or other bodily cavity, tract, or duct.
    Type: Application
    Filed: December 19, 2019
    Publication date: April 23, 2020
    Applicant: AEGEA Medical Inc.
    Inventors: Daniel Van Zandt MOYER, Uriel Hiram CHEE, Torrey Pine SMITH, Hugh Edward MAGEN, Darin Charles GITTINGS
  • Patent number: 10575898
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Grant
    Filed: May 24, 2019
    Date of Patent: March 3, 2020
    Assignee: AEGEA MEDICAL INC.
    Inventors: Uriel Hiram Chee, Robert Bilgor Peliks, Hugh Edward Magen, Donnell William Gurskis, Steven Robert Bacich
  • Publication number: 20200014609
    Abstract: Embodiments provide optimized deployment of workloads. A first workload to be deployed in at least one data center of a plurality of data centers is received. A first plurality of candidate data centers is selected from the plurality of data centers, and the first workload is deployed to each of the first plurality of candidate data centers. A first performance metric is collected from each respective data center of the first plurality of candidate data centers based on execution of the first workload deployed at the respective data centers, and a first optimal data center from the first plurality of candidate data centers is identified based on the first performance metrics. The first workload is removed from each of the first plurality of candidate data centers, other than the identified first optimal data center.
    Type: Application
    Filed: July 6, 2018
    Publication date: January 9, 2020
    Inventors: Hugh Edward HOCKETT, Lin Sun, Aaron James Quirk
  • Publication number: 20190274756
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Application
    Filed: May 24, 2019
    Publication date: September 12, 2019
    Inventors: Uriel Hiram CHEE, Robert Bilgor PELIKS, Hugh Edward MAGEN, Donnell William GURSKIS, Steven Robert BACICH
  • Publication number: 20190216523
    Abstract: A method and system of providing therapy to a patient's uterus. The method can include the steps of inserting a uterine ablation device into the uterus; expanding a distal anchor; inflating a proximal balloon to pull the distal anchor proximally and seat the distal anchor against the internal os of the uterus; inflating a central balloon to seal the cervix; delivering vapor from the uterine ablation device into the uterus; and condensing the vapor on tissue within the uterus. The system can include a cervical collar adapted to place a distal portion of the device within the uterus when the cervical collar contacts an external os of the cervix.
    Type: Application
    Filed: March 25, 2019
    Publication date: July 18, 2019
    Applicant: AEGEA MEDICAL INC.
    Inventors: Donnell William GURSKIS, Robert Bilgor PELIKS, Hugh Edward MAGEN, Roxanne DANIELS, Steven Robert BACICH
  • Patent number: 10299856
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: May 28, 2019
    Assignee: AEGEA MEDICAL INC.
    Inventors: Uriel Hiram Chee, Robert Bilgor Peliks, Hugh Edward Magen, Donnell William Gurskis, Steven Robert Bacich
  • Publication number: 20190142496
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Application
    Filed: January 15, 2019
    Publication date: May 16, 2019
    Applicant: AEGEA MEDICAL INC.
    Inventors: Uriel Hiram CHEE, Robert Bilgor PELIKS, Hugh Edward MAGEN, Donnell William GURSKIS, Steven Robert BACICH
  • Patent number: 10238446
    Abstract: A method and system of providing therapy to a patient's uterus. The method can include the steps of inserting a uterine ablation device into the uterus; expanding a distal anchor; inflating a proximal balloon to pull the distal anchor proximally and seat the distal anchor against the internal os of the uterus; inflating a central balloon to seal the cervix; delivering vapor from the uterine ablation device into the uterus; and condensing the vapor on tissue within the uterus. The can include a cervical collar adapted to place a distal portion of the device within the uterus when the cervical collar contacts an external os of the cervix.
    Type: Grant
    Filed: August 29, 2017
    Date of Patent: March 26, 2019
    Assignee: AEGEA MEDICAL INC.
    Inventors: Donnell William Gurskis, Robert Bilgor Peliks, Hugh Edward Magen, Roxanne Daniels, Steven Robert Bacich
  • Publication number: 20190038210
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. Systems for performing these methods with monitored flow rate and independent of patient height relative to the pressure source are also disclosed.
    Type: Application
    Filed: February 21, 2017
    Publication date: February 7, 2019
    Applicant: AEGEA MEDICAL INC.
    Inventors: Robert Bilgor PELIKS, Darin Charles GITTINGS, Hugh Edward MAGEN, Uriel Hiram CHEE
  • Patent number: 10179019
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: January 15, 2019
    Assignee: AEGEA MEDICAL INC.
    Inventors: Uriel Hiram Chee, Robert Bilgor Peliks, Hugh Edward Magen, Donnell William Gurskis, Steven Robert Bacich
  • Publication number: 20180363648
    Abstract: A fluid transfer device comprising an inner member with a central axis and an outer surface; an outer member coaxially arranged with the inner member, and a space defined radially between the inner and outer members; a first and second axial members; at least one fluid chamber defined in the space having an inlet and an outlet; the first axial member is rotationally fixed relative to the outer member and the second axial member is rotatable about the central axis to vary the volume of the fluid chamber. The relative rotational position of the first and second axial members is defined by a cam arrangement which comprises first and second axial member walls; the first axial member wall forms a first cam track wall which provides a first cam track waveform, the second axial member wall which comprises a second cam track wall; each cam track wall is circumferentially continuous.
    Type: Application
    Filed: February 13, 2018
    Publication date: December 20, 2018
    Inventor: Hugh Edward Fisher
  • Publication number: 20180289416
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Application
    Filed: June 12, 2018
    Publication date: October 11, 2018
    Inventors: Uriel Hiram CHEE, Robert Bilgor PELIKS, Hugh Edward MAGEN, Donnell William GURSKIS, Steven Robert BACICH
  • Publication number: 20180258474
    Abstract: Disclosed are methods for polynucleotide sequencing that detect the location of selected nucleobases with greater precision. The methods can be used to determine the location and nature of modified bases in a polynucleotide, that is, non-canonical bases, or to improve accuracy of sequencing of “problem” regions of DNA sequencing such as homopolymers, GC rich areas, etc. The sequencing method exemplified is nanopore sequencing. Nanopore sequencing is used to generate a unique signal at a point in a polynucleotide sequence where an abasic site (AP site, or apurinic or apyrimidinic site) exists. As part of the method, an abasic site is specifically created enzymatically using a DNA glycosylase that recognizes a pre-determined nucleobase species and cleaves the N-glycosidic bond to release only that base, leaving an AP site in its place.
    Type: Application
    Filed: April 5, 2016
    Publication date: September 13, 2018
    Inventors: Miten Jain, Hugh Edward Olsen, Mark A. Akeson
  • Patent number: 9993290
    Abstract: A method and system of providing therapy to a patient's uterus is provided, which can include any number of features. The method can include the steps of inserting a uterine device into the uterus and performing a uterine integrity test to determine that the uterus is intact and not perforated. If it is determined that the uterus is not perforated, a patency test can be performed to determine that the uterine device is not clogged or embedded in tissue. If the uterus is intact and the device is not clogged or embedded in tissue, the uterus can be treated with the uterine device, e.g., uterine ablation. Systems for performing these methods are also disclosed.
    Type: Grant
    Filed: May 21, 2015
    Date of Patent: June 12, 2018
    Assignee: AEGEA MEDICAL INC.
    Inventors: Uriel Hiram Chee, Robert Bilgor Peliks, Hugh Edward Magen, Donnell William Gurskis, Steven Robert Bacich
  • Publication number: 20170354452
    Abstract: A method and system of providing therapy to a patient's uterus. The method can include the steps of inserting a uterine ablation device into the uterus; expanding a distal anchor; inflating a proximal balloon to pull the distal anchor proximally and seat the distal anchor against the internal os of the uterus; inflating a central balloon to seal the cervix; delivering vapor from the uterine ablation device into the uterus; and condensing the vapor on tissue within the uterus. The can include a cervical collar adapted to place a distal portion of the device within the uterus when the cervical collar contacts an external os of the cervix.
    Type: Application
    Filed: August 29, 2017
    Publication date: December 14, 2017
    Inventors: Donnell William GURSKIS, Robert Bilgor PELIKS, Hugh Edward MAGEN, Roxanne DANIELS, Steven Robert BACICH
  • Patent number: 9743974
    Abstract: A method and system of providing therapy to a patient's uterus. The method can include the steps of inserting a uterine ablation device into the uterus; expanding a distal anchor; inflating a proximal balloon to pull the distal anchor proximally and seat the distal anchor against the internal os of the uterus; inflating a central balloon to seal the cervix; delivering vapor from the uterine ablation device into the uterus; and condensing the vapor on tissue within the uterus. The can include a cervical collar adapted to place a distal portion of the device within the uterus when the cervical collar contacts an external os of the cervix.
    Type: Grant
    Filed: November 9, 2011
    Date of Patent: August 29, 2017
    Assignee: AEGEA MEDICAL INC.
    Inventors: Donnell William Gurskis, Robert Bilgor Peliks, Hugh Edward Magen, Roxanne Daniels, Steven Robert Bacich